QTXB Monthly Line Chart (bottom feeder)QTXB every so slowly creeping up this lower trendline. An absolute class act bottom feeder.
63.94 M
About QuantRX Biomedical Corp.
Sector
Industry
CEO
Shalom Z. Hirschman
Headquarters
Tualatin
Founded
1986
FIGI
BBG000DJW365
QuantRx Biomedical Corp. engages in developing and commercializing its patented miniform pads (PADs) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. The firm also develops and intends to commercialize genomic diagnostics for the laboratory market, based on its lateral flow patents. Its platforms include inSync, UniqueTM, and original equipment manufacturer branded over-the-counter and laboratory testing products. The company was founded on December 5, 1986 and is headquartered in Tualatin, OR.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of QTXB is 0.0040 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange QuantRX Biomedical Corp. stocks are traded under the ticker QTXB.
QTXB stock is 0% volatile and has beta coefficient of 5.34 K. Check out the list of the most volatile stocks — is QuantRX Biomedical Corp. there?
Yes, you can track QuantRX Biomedical Corp. financials in yearly and quarterly reports right on TradingView.
No, QTXB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, QTXB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QuantRX Biomedical Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QuantRX Biomedical Corp. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QuantRX Biomedical Corp. stock shows the sell signal. See more of QuantRX Biomedical Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.